{"content":"<li class=\"n-box-item date-title\" data-end=\"1333166399\" data-start=\"1333080000\" data-txt=\"Wednesday, December 18, 2019\">Friday, March 30, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"230321\" data-ts=\"1333148583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/230321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Threshold Pharmaceuticals (THLD +4.5%), which rallied today after its TH-302 drug received...</a></h4><p>Threshold Pharmaceuticals (THLD <font color=\"green\">+4.5%</font>), which rallied today after its <a target=\"_blank\" href=\"http://www.thresholdpharm.com/sec/tumor_hypoxia\">TH-302</a> drug <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228551\">received orphan status</a> from the FDA, <font color=\"red\">falls 2.3%</font> AH after providing <a target=\"_blank\" href=\"http://finance.yahoo.com/news/threshold-pharmaceuticals-announces-detailed-results-201000137.html\">detailed clinical results</a> for the drug's Phase 2b trials, which evaluate its efficacy in treating pancreatic cancer. </p><div class=\"tiny-share-widget\" data-id=\"230321\" data-linked=\"Threshold Pharmaceuticals (THLD +4.5%), which rallied today after its TH-302 drug received...\" data-tweet=\"$MTEM - Threshold Pharmaceuticals (THLD +4.5%), which rallied today after its TH-302 drug received orphan status from the FDA, falls 2.3% AH after providing detailed clinical results for the drug&#39;s Phase 2b trials, which evaluate its efficacy in treatin... https://seekingalpha.com/news/230321?source=tweet\" data-url=\"https://seekingalpha.com/news/230321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"230111\" data-ts=\"1333140403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/230111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research In Motion (RIMM +7.1%) ends the day with a healthy gain, as optimism about Thorsten...</a></h4><p>Research In Motion (RIMM <font color=\"green\">+7.1%</font>) ends the day with a healthy gain, as optimism about Thorsten Heins' willingness to clean house and explore options outweighs pessimism about <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227911\">bleak results</a> and discontinued guidance. The rally comes even though sell-side opinions are <a target=\"_blank\" href=\"http://blogs.barrons.com/techtraderdaily/2012/03/30/rimm-jumps-7-newfound-frankness-vies-with-vagueness/\">almost uniformly bearish</a> (one more way in which RIM is the anti-Apple), and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228251\">buyout speculation</a> is largely <a target=\"_blank\" href=\"http://dealbook.nytimes.com/2012/03/30/for-struggling-rim-sale-prospects-appear-tough/\">downbeat</a>. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=rimm\">more</a>) </p><div class=\"tiny-share-widget\" data-id=\"230111\" data-linked=\"Research In Motion (RIMM +7.1%) ends the day with a healthy gain, as optimism about Thorsten...\" data-tweet=\"$BB - Research In Motion (RIMM +7.1%) ends the day with a healthy gain, as optimism about Thorsten Heins&#39; willingness to clean house and explore options outweighs pessimism about bleak results and discontinued guidance. The rally comes even though sell-... https://seekingalpha.com/news/230111?source=tweet\" data-url=\"https://seekingalpha.com/news/230111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"230081\" data-ts=\"1333139615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/230081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon (NASDAQ:GRPN) -10.5% AH after revising its Q4 revenue downward by $14.3M, and its EPS by...</a></h4><p>Groupon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a>) <font color=\"red\">-10.5%</font> AH after <a target=\"_blank\" href=\"http://finance.yahoo.com/news/groupon-announces-revised-fourth-quarter-201500991.html\">revising</a> its Q4 revenue downward by $14.3M, and its EPS by $0.04, on account of an increase in the company's refund reserve accrual. Details about the increase, which relate to a sales mix shift, are provided in Groupon's just-filed <a target=\"_blank\" href=\"http://sec.gov/Archives/edgar/data/1490281/000144530512000922/groupon10-k.htm\">10-K</a>, which also includes a disclosure of \"material weakness\" in internal controls. The company is reaffirming its Q1 guidance. </p><div class=\"tiny-share-widget\" data-id=\"230081\" data-linked=\"Groupon (NASDAQ:GRPN) -10.5% AH after revising its Q4 revenue downward by $14.3M, and its EPS by...\" data-tweet=\"$GRPN - Groupon (NASDAQ:GRPN) -10.5% AH after revising its Q4 revenue downward by $14.3M, and its EPS by $0.04, on account of an increase in the company&#39;s refund reserve accrual. Details about the increase, which relate to a sales mix shift, are provide... https://seekingalpha.com/news/230081?source=tweet\" data-url=\"https://seekingalpha.com/news/230081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"230011\" data-ts=\"1333137489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/230011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy (BBY -4.4%) adds to yesterday&#39;s big losses after poor Q4 results, and pundits ask how...</a></h4> Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color=\"red\">-4.4%</font>) adds to yesterday's big losses after poor <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/226661\" target=\"_blank\">Q4 results</a>, and pundits ask how it can compete with Amazon and the broader implications for how consumers buy technology (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/229171\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/article/469011-best-buy-s-collapse-signals-major-changes-in-consumer-technology\">II</a>, <a target=\"_blank\" href=\"http://beta.fool.com/tigeranalyst/2012/03/30/best-buy-announces-restructuring-it-enough/3272/?ticker=BBY&amp;source=eogyholnk0000001\">III</a>). UBS asks: \"<a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/UBS+Asks+Best+Buy+%28BBY%29%3A+Will+It+Work%3F+Theres+No+Simple+Answer/7309806.html\" target=\"_blank\">Will it work?</a> [What will] convince the  market that the company is serious about taking steep steps to evolve  with the changing marketplace... in reality, only time will tell.\" <div class=\"tiny-share-widget\" data-id=\"230011\" data-linked=\"Best Buy (BBY -4.4%) adds to yesterday&#39;s big losses after poor Q4 results, and pundits ask how...\" data-tweet=\"$BBY - Best Buy (BBY -4.4%) adds to yesterday&#39;s big losses after poor Q4 results, and pundits ask how it can compete with Amazon and the broader implications for how consumers buy technology (I, II, III). UBS asks: &quot;Will it work? [What will] convince th... https://seekingalpha.com/news/230011?source=tweet\" data-url=\"https://seekingalpha.com/news/230011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229991\" data-ts=\"1333137034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNY\" target=\"_blank\">JNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Jones Group (JNY +7.4%) pops after SunTrust upgraded the shares to Buy ahead of its April 25...</a></h4><p>The Jones Group (<a href=\"https://seekingalpha.com/symbol/JNY\" title=\"The Jones Group Inc.\">JNY</a> <font color=\"green\">+7.4%</font>) pops after SunTrust <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/SunTrust+Robinson+Humphrey+Upgrades+Jones+Apparel+Group+%28JNY%29+to+Buy/7309325.html\">upgraded the shares</a> to Buy ahead of its April 25 report, citing expectations for traction in its Spring product line and benefits from its restructuring initiatives. </p><div class=\"tiny-share-widget\" data-id=\"229991\" data-linked=\"The Jones Group (JNY +7.4%) pops after SunTrust upgraded the shares to Buy ahead of its April 25...\" data-tweet=\"$JNY - The Jones Group (JNY +7.4%) pops after SunTrust upgraded the shares to Buy ahead of its April 25 report, citing expectations for traction in its Spring product line and benefits from its restructuring initiatives. https://seekingalpha.com/news/229991?source=tweet\" data-url=\"https://seekingalpha.com/news/229991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229981\" data-ts=\"1333136368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Teva Pharmaceutical (TEVA +2.2%) move up after the company announces the launch of the...</a></h4><p>Shares of Teva Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a> <font color=\"green\">+2.2%</font>) move up after the company <a target=\"_blank\" href=\"http://finance.yahoo.com/news/teva-announces-launch-authorized-generic-120000882.html\">announces</a> the launch of the authorized generic version of Provigil, a drug used to treat excessive sleepiness caused by narcolepsy. </p><div class=\"tiny-share-widget\" data-id=\"229981\" data-linked=\"Shares of Teva Pharmaceutical (TEVA +2.2%) move up after the company announces the launch of the...\" data-tweet=\"$TEVA - Shares of Teva Pharmaceutical (TEVA +2.2%) move up after the company announces the launch of the authorized generic version of Provigil, a drug used to treat excessive sleepiness caused by narcolepsy. https://seekingalpha.com/news/229981?source=tweet\" data-url=\"https://seekingalpha.com/news/229981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229971\" data-ts=\"1333136203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movado (MOV +1.3%) gains after Citigroup increases its price target to $28 from $24 on the...</a></h4><p>Movado (<a href=\"https://seekingalpha.com/symbol/MOV\" title=\"Movado Group, Inc.\">MOV</a> <font color=\"green\">+1.3%</font>) gains after Citigroup increases its <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=mov&amp;days_back=30&amp;table=none\">price target</a> to $28 from $24 on the company's better-than-expected Q4 EPS yesterday. The firm reiterates its Buy rating on the stock. </p><div class=\"tiny-share-widget\" data-id=\"229971\" data-linked=\"Movado (MOV +1.3%) gains after Citigroup increases its price target to $28 from $24 on the...\" data-tweet=\"$MOV - Movado (MOV +1.3%) gains after Citigroup increases its price target to $28 from $24 on the company&#39;s better-than-expected Q4 EPS yesterday. The firm reiterates its Buy rating on the stock. https://seekingalpha.com/news/229971?source=tweet\" data-url=\"https://seekingalpha.com/news/229971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229891\" data-ts=\"1333133990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS +5.3%) and Arena Pharmaceuticals (ARNA +0.3%), competing to win U.S. regulatory...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+5.3%</font>) and Arena Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"green\">+0.3%</font>), competing to win U.S. regulatory approval for weight-loss treatments, <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-03-30/vivus-arena-unlikely-to-be-affected-by-fda-obesity-panel.html\">probably won\u2019t be affected</a> by an FDA advisory panel\u2019s <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227751\">recommendation</a> for heart-risk studies, an FDA spokesperson tells Bloomberg: \u201cIt\u2019s unlikely that the discussions over the past couple days will impact any existing applications.\" (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228481\">also</a>) </p><div class=\"tiny-share-widget\" data-id=\"229891\" data-linked=\"Vivus (VVUS +5.3%) and Arena Pharmaceuticals (ARNA +0.3%), competing to win U.S. regulatory...\" data-tweet=\"$VVUS $VVUS $ARNA - Vivus (VVUS +5.3%) and Arena Pharmaceuticals (ARNA +0.3%), competing to win U.S. regulatory approval for weight-loss treatments, probably won\u2019t be affected by an FDA advisory panel\u2019s recommendation for heart-risk studies, an FDA spok... https://seekingalpha.com/news/229891?source=tweet\" data-url=\"https://seekingalpha.com/news/229891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229881\" data-ts=\"1333133550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KWK\" target=\"_blank\">KWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quicksilver Resources (KWK -4.4%) names controller John Regan as its new CFO, replacing current...</a></h4><p>Quicksilver Resources (<a href=\"https://seekingalpha.com/symbol/KWK\" title=\"Quicksilver Resources Inc.\">KWK</a> <font color=\"red\">-4.4%</font>) names controller  John Regan as its new CFO, <a target=\"_blank\" href=\"http://www.marketwire.com/press-release/quicksilver-resources-announces-appointment-of-new-chief-financial-officer-nyse-kwk-1638125.htm\">replacing current</a> CFO  Philip Cook who plans to resign next month after the company files its 2011 annual report. </p><div class=\"tiny-share-widget\" data-id=\"229881\" data-linked=\"Quicksilver Resources (KWK -4.4%) names controller John Regan as its new CFO, replacing current...\" data-tweet=\"$KWK - Quicksilver Resources (KWK -4.4%) names controller John Regan as its new CFO, replacing current CFO Philip Cook who plans to resign next month after the company files its 2011 annual report. https://seekingalpha.com/news/229881?source=tweet\" data-url=\"https://seekingalpha.com/news/229881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229871\" data-ts=\"1333133300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers show continued strength on sentiment that the Supreme Court may significantly...</a></h4><p>Health insurers show continued strength on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/226841\">sentiment</a> that the Supreme Court may significantly overturn Obamacare, <a target=\"_blank\" href=\"http://www.marketwatch.com/story/insurers-continue-to-rally-in-wake-of-hearings-2012-03-30\">boosted</a> by a Jefferies note saying a court ruling that would overturn part of the law that  would order states to expand Medicaid programs probably won\u2019t have long-lasting effects on insurers such as <a href=\"https://seekingalpha.com/symbol/CNC\" title=\"Centene Corporation\">CNC</a> <font color=\"green\">+3.6%</font> and AGP <font color=\"green\">+3%</font>. Also: WLP <font color=\"green\">+3.5%</font>, CVH <font color=\"green\">+3%</font>, <a href=\"https://seekingalpha.com/symbol/WCG\" title=\"WellCare Health Plans, Inc.\">WCG</a> <font color=\"green\">+2.7%</font>. </p><div class=\"tiny-share-widget\" data-id=\"229871\" data-linked=\"Health insurers show continued strength on sentiment that the Supreme Court may significantly...\" data-tweet=\"$CNC $CNC $ANTM - Health insurers show continued strength on sentiment that the Supreme Court may significantly overturn Obamacare, boosted by a Jefferies note saying a court ruling that would overturn part of the law that would order states to expand M... https://seekingalpha.com/news/229871?source=tweet\" data-url=\"https://seekingalpha.com/news/229871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229861\" data-ts=\"1333132952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple (AAPL -1.6%) is underperforming today on above-average volume. The Fair Labor...</a></h4> Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color=\"red\">-1.6%</font>) is underperforming today on above-average volume. The Fair Labor Association's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227831\">discovery</a> of \"non-compliances\" at Foxconn's Chinese facilities, together with Apple and Foxconn's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228331\">agreement</a> to address the issues via new hiring and other measures, could have investors worried Apple will see <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/180641\">higher manufacturing costs</a> and lower margins. <div class=\"tiny-share-widget\" data-id=\"229861\" data-linked=\"Apple (AAPL -1.6%) is underperforming today on above-average volume. The Fair Labor...\" data-tweet=\"$AAPL - Apple (AAPL -1.6%) is underperforming today on above-average volume. The Fair Labor Association&#39;s discovery of &quot;non-compliances&quot; at Foxconn&#39;s Chinese facilities, together with Apple and Foxconn&#39;s agreement to address the issues via new hiring an... https://seekingalpha.com/news/229861?source=tweet\" data-url=\"https://seekingalpha.com/news/229861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229801\" data-ts=\"1333132080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StemCells (STEM +2%) moves higher after announcing a conference call to discuss results from its...</a></h4> StemCells (STEM <font color=\"green\">+2%</font>) moves higher after announcing a <a target=\"_blank\" href=\"http://www.globenewswire.com/newsroom/news.html?d=250699\">conference call</a> to discuss results from its Phase I clinical trial of HuCNS-SC - purified human neural stem cells used as a potential treatment for PMD, a rare hypo-myelination disorder in children. <div class=\"tiny-share-widget\" data-id=\"229801\" data-linked=\"StemCells (STEM +2%) moves higher after announcing a conference call to discuss results from its...\" data-tweet=\"$MBOT - StemCells (STEM +2%) moves higher after announcing a conference call to discuss results from its Phase I clinical trial of HuCNS-SC - purified human neural stem cells used as a potential treatment for PMD, a rare hypo-myelination disorder in chi... https://seekingalpha.com/news/229801?source=tweet\" data-url=\"https://seekingalpha.com/news/229801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229781\" data-ts=\"1333131621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACH\" target=\"_blank\">CACH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cache (OTC:CACH -10.4%) sinks after its Q4 meets expectations on revenue but misses on a per...</a></h4><p>Cache (<a href=\"https://seekingalpha.com/symbol/CACH\" title=\"Cache, Inc.\">OTC:CACH</a> <font color=\"red\">-10.4%</font>) sinks after its Q4 meets expectations on revenue but <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/227951\">misses on a per share basis</a>. The company posted weaker-than-expected profit as promotional activity pressured margins. The company also warns on the current quarter, saying that lower sales for special-occasion apparel and some spring merchandise forced it to increase promotional activity, which will likely pressure Q1 margins. </p><div class=\"tiny-share-widget\" data-id=\"229781\" data-linked=\"Cache (OTC:CACH -10.4%) sinks after its Q4 meets expectations on revenue but misses on a per...\" data-tweet=\"$CACH - Cache (OTC:CACH -10.4%) sinks after its Q4 meets expectations on revenue but misses on a per share basis. The company posted weaker-than-expected profit as promotional activity pressured margins. The company also warns on the current quarter, sa... https://seekingalpha.com/news/229781?source=tweet\" data-url=\"https://seekingalpha.com/news/229781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229761\" data-ts=\"1333131251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KATE\" target=\"_blank\">KATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Liz Claiborne (LIZ) roar 15.3% higher to $13.70 off of a report that the retailer is...</a></h4>Shares of Liz Claiborne (LIZ) roar <font color=\"green\">15.3% higher</font> to $13.70 off of a <a target=\"_blank\" href=\"https://twitter.com/#!/Street_Insider/status/185790769494368256\">report</a> that the retailer is talking to P-E firms with a goal of nabbing $20 a share from an acquirer. <div class=\"tiny-share-widget\" data-id=\"229761\" data-linked=\"Shares of Liz Claiborne (LIZ) roar 15.3% higher to $13.70 off of a report that the retailer is...\" data-tweet=\"$KATE - Shares of Liz Claiborne (LIZ) roar 15.3% higher to $13.70 off of a report that the retailer is talking to P-E firms with a goal of nabbing $20 a share from an acquirer. https://seekingalpha.com/news/229761?source=tweet\" data-url=\"https://seekingalpha.com/news/229761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229741\" data-ts=\"1333130585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KND\" target=\"_blank\">KND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kindred Healthcare (KND -3%) and Select Medical (SEM -3.5%) slump after Susquehanna cut the...</a></h4> Kindred Healthcare (<a href='https://seekingalpha.com/symbol/KND' title='Kindred Healthcare, Inc.'>KND</a> <font color=\"red\">-3%</font>) and Select Medical (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color=\"red\">-3.5%</font>) slump after Susquehanna <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=knd&amp;days_back=30&amp;table=none\">cut the health-facility operators to Neutral</a> earlier this morning. The firm sees the stocks remaining range-bound until there is greater clarity on potential Medicare reimbursement challenges facing the companies. Wells Fargo also cut both companies to Outperform as well. <div class=\"tiny-share-widget\" data-id=\"229741\" data-linked=\"Kindred Healthcare (KND -3%) and Select Medical (SEM -3.5%) slump after Susquehanna cut the...\" data-tweet=\"$KND $KND $SEM - Kindred Healthcare (KND -3%) and Select Medical (SEM -3.5%) slump after Susquehanna cut the health-facility operators to Neutral earlier this morning. The firm sees the stocks remaining range-bound until there is greater clarity on pote... https://seekingalpha.com/news/229741?source=tweet\" data-url=\"https://seekingalpha.com/news/229741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229721\" data-ts=\"1333130328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAZA\" target=\"_blank\">ZAZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229721\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small-time oil producer ZaZa Energy (OTC:ZAZA +22%) soars after announcing plans to expand the...</a></h4><p>Small-time oil producer ZaZa Energy (<a href=\"https://seekingalpha.com/symbol/ZAZA\" title=\"ZaZa Energy Corp\">OTC:ZAZA</a> <font color=\"green\">+22%</font>) soars after <a target=\"_blank\" href=\"http://www.marketwatch.com/story/zaza-energy-expands-to-140000-acres-in-the-texas-eaglebine-and-commences-six-well-drilling-program-2012-03-29\">announcing plans</a> to expand the size of its operations in Texas' <a target=\"_blank\" href=\"http://www.eaglefordshale.com/geology/\">Eaglebine</a> formation to 144K gross acres, courtesy of a deal with Range Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/RRC\" title=\"Range Resources Corporation\">RRC</a>). Also helping is a <a target=\"_blank\" href=\"http://www.streetinsider.com/Momentum+Movers/ZaZa+Energy+%28ZAZA%29+Shares+Jump+as+CNBC+Trader+Recommends/7309839.html\">positive mention</a> on CNBC's <em>Fast Money Halftime Report</em>. </p><div class=\"tiny-share-widget\" data-id=\"229721\" data-linked=\"Small-time oil producer ZaZa Energy (OTC:ZAZA +22%) soars after announcing plans to expand the...\" data-tweet=\"$ZAZA $ZAZA $RRC - Small-time oil producer ZaZa Energy (OTC:ZAZA +22%) soars after announcing plans to expand the size of its operations in Texas&#39; Eaglebine formation to 144K gross acres, courtesy of a deal with Range Resources (NYSE:RRC). Also helping ... https://seekingalpha.com/news/229721?source=tweet\" data-url=\"https://seekingalpha.com/news/229721\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229701\" data-ts=\"1333129755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIBX\" target=\"_blank\">TIBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In spite of beating FQ1 estimates and announcing a $300M stock buyback, Tibco (TIBX -5.6%) is...</a></h4> In spite of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227901\">beating</a> FQ1 estimates and announcing a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227931\">$300M stock buyback</a>, Tibco (<a href='https://seekingalpha.com/symbol/TIBX' title='TIBCO Software, Inc.'>TIBX</a> <font color=\"red\">-5.6%</font>) is selling off, thanks to the richly-valued middleware maker's <a target=\"_blank\" href=\"http://wallstcheatsheet.com/stocks/tibco-software-earnings-stock-buyback-not-enough.html/\">guidance</a> for FQ2 revenue of $240M-$244M and EPS of $0.22-$0.23 (consensus is for $242.2M and $0.23). <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/UBS+Maintains+a+Buy+on+Tibco+Software+%28TIBX%29%3B+Beating+Consensus+For+The+15th+Consecutive+Qtr/7309978.html\">UBS</a> (Buy) is staying positive: it likes the increase seen in Tibco's average deal size, and expects its huge sales investments to pay off in 2H. (<a target=\"_blank\" href=\"https://seekingalpha.com/article/467171-tibco-software-s-ceo-discusses-q1-2012-results-earnings-call-transcript\">transcript</a>) <div class=\"tiny-share-widget\" data-id=\"229701\" data-linked=\"In spite of beating FQ1 estimates and announcing a $300M stock buyback, Tibco (TIBX -5.6%) is...\" data-tweet=\"$TIBX - In spite of beating FQ1 estimates and announcing a $300M stock buyback, Tibco (TIBX -5.6%) is selling off, thanks to the richly-valued middleware maker&#39;s guidance for FQ2 revenue of $240M-$244M and EPS of $0.22-$0.23 (consensus is for $242.2M an... https://seekingalpha.com/news/229701?source=tweet\" data-url=\"https://seekingalpha.com/news/229701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229671\" data-ts=\"1333128941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUFK\" target=\"_blank\">LUFK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lufkin Industries (LUFK +3.5%) rallies after Dahlman Rose starts coverage with a Buy and $96 PT....</a></h4><p>Lufkin Industries (<a href=\"https://seekingalpha.com/symbol/LUFK\" title=\"Lufkin Industries, Inc.\">LUFK</a> <font color=\"green\">+3.5%</font>) rallies after <a target=\"_blank\" href=\"http://www.streetinsider.com/New+Coverage/Dahlman+Rose+Starts+Lufkin+Industries+%28LUFK%29+at+Buy%3B+Benefit+From+Booming+Oil+Activity/7308637.html\">Dahlman Rose</a> starts coverage with a Buy and $96 PT. The firm thinks price increases for Lufkin's <a target=\"_blank\" href=\"http://www.lufkin.com/index.php/products-a-services/oilfield\">aritifical lift</a> equipment for oil production will drive margin expansion and EPS upside, as well as lead to higher guidance. It also thinks greater operational efficiencies could boost margins. </p><div class=\"tiny-share-widget\" data-id=\"229671\" data-linked=\"Lufkin Industries (LUFK +3.5%) rallies after Dahlman Rose starts coverage with a Buy and $96 PT....\" data-tweet=\"$LUFK - Lufkin Industries (LUFK +3.5%) rallies after Dahlman Rose starts coverage with a Buy and $96 PT. The firm thinks price increases for Lufkin&#39;s aritifical lift equipment for oil production will drive margin expansion and EPS upside, as well as lea... https://seekingalpha.com/news/229671?source=tweet\" data-url=\"https://seekingalpha.com/news/229671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229641\" data-ts=\"1333127678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISCA\" target=\"_blank\">DISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Discovery Communications (DISCA +1.8%) gains after Lazard Capital upped the shares to Buy...</a></h4> Discovery Communications (<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a> <font color=\"green\">+1.8%</font>) gains after Lazard Capital <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=disca&amp;days_back=30&amp;table=none\">upped the shares</a> to Buy earlier today, based on domestic momentum in at Discovery ID, network expansion globally and domestic higher ratings at Discovery Network. <div class=\"tiny-share-widget\" data-id=\"229641\" data-linked=\"Discovery Communications (DISCA +1.8%) gains after Lazard Capital upped the shares to Buy...\" data-tweet=\"$DISCA - Discovery Communications (DISCA +1.8%) gains after Lazard Capital upped the shares to Buy earlier today, based on domestic momentum in at Discovery ID, network expansion globally and domestic higher ratings at Discovery Network. https://seekingalpha.com/news/229641?source=tweet\" data-url=\"https://seekingalpha.com/news/229641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229601\" data-ts=\"1333126228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A number of payment processing stocks are getting tossed around after news breaks that Global...</a></h4><p>A number of payment processing stocks are getting tossed around after <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/229551\">news breaks</a> that Global Payments could be the culprit <a target=\"_blank\" href=\"https://twitter.com/#!/CNBC/status/185761916952641537\">behind the security breach</a> of credit card data. Decliners: HPY <font color=\"red\">-2.5%</font>, <a href=\"https://seekingalpha.com/symbol/MGI\" title=\"MoneyGram International, Inc.\">MGI</a> <font color=\"red\">-0.8%</font>, <a href=\"https://seekingalpha.com/symbol/NEWT\" title=\"Newtek Business Services Inc.\">NEWT</a> <font color=\"red\">-1.4%</font>,  <a href=\"https://seekingalpha.com/symbol/FLT\" title=\"FleetCor Technologies, Inc.\">FLT</a> <font color=\"red\">-0.7%</font>, <a href=\"https://seekingalpha.com/symbol/UEPS\" title=\"Net 1 UEPS Technologies, Inc.\">UEPS</a> <font color=\"red\">-2.0%</font>.</p><div class=\"tiny-share-widget\" data-id=\"229601\" data-linked=\"A number of payment processing stocks are getting tossed around after news breaks that Global...\" data-tweet=\"$GPN $GPN $MGI - A number of payment processing stocks are getting tossed around after news breaks that Global Payments could be the culprit behind the security breach of credit card data. Decliners: HPY -2.5%, MGI -0.8%, NEWT -1.4%, FLT -0.7%, UEPS -2.0%. https://seekingalpha.com/news/229601?source=tweet\" data-url=\"https://seekingalpha.com/news/229601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229571\" data-ts=\"1333125876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney (DIS +1.4%) gains on an upgrade to Buy on valuation at Lazard Capital, citing secular...</a></h4><p>Disney (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"green\">+1.4%</font>) gains on an <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=dis&amp;days_back=30&amp;table=none\">upgrade to Buy</a> on valuation at Lazard Capital, citing secular positive program fee growth, and a strong net cash position that can be used for repurchases or acquisitions. </p><div class=\"tiny-share-widget\" data-id=\"229571\" data-linked=\"Disney (DIS +1.4%) gains on an upgrade to Buy on valuation at Lazard Capital, citing secular...\" data-tweet=\"$DIS - Disney (DIS +1.4%) gains on an upgrade to Buy on valuation at Lazard Capital, citing secular positive program fee growth, and a strong net cash position that can be used for repurchases or acquisitions. https://seekingalpha.com/news/229571?source=tweet\" data-url=\"https://seekingalpha.com/news/229571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229551\" data-ts=\"1333125459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading is halted in Global Payments (GPN -9.1%) as the credit card industry investigates a data...</a></h4><a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-03-30/global-payments-trades-halt-as-card-industry-probes-data-breach.html\">Trading is halted</a> in Global Payments (<a href=\"https://seekingalpha.com/symbol/GPN\" title=\"Global Payments Inc.\">GPN</a> <font color=\"red\">-9.1%</font>) as the credit card industry investigates a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/229061\">data breach</a> that affected Visa and MasterCard. GPN shares had dropped as much as 13% when trading stopped in New York pending further news. <div class=\"tiny-share-widget\" data-id=\"229551\" data-linked=\"Trading is halted in Global Payments (GPN -9.1%) as the credit card industry investigates a data...\" data-tweet=\"$GPN - Trading is halted in Global Payments (GPN -9.1%) as the credit card industry investigates a data breach that affected Visa and MasterCard. GPN shares had dropped as much as 13% when trading stopped in New York pending further news. https://seekingalpha.com/news/229551?source=tweet\" data-url=\"https://seekingalpha.com/news/229551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229451\" data-ts=\"1333124255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero Energy (VLO -4.2%) is the S&amp;amp;P&#39;s leading loser so far after Credit Suisse cuts 2012...</a></h4> Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color=\"red\">-4.2%</font>) is the S&amp;P's leading loser so far after Credit Suisse cuts 2012 earnings estimates, citing \"weak retail margins, VLO-specific refinery maintenance and weak ethanol margins. With a potentially sluggish patch for the economy, refiner shares could consolidate here.\" <div class=\"tiny-share-widget\" data-id=\"229451\" data-linked=\"Valero Energy (VLO -4.2%) is the S&amp;amp;P&#39;s leading loser so far after Credit Suisse cuts 2012...\" data-tweet=\"$VLO - Valero Energy (VLO -4.2%) is the S&amp;P&#39;s leading loser so far after Credit Suisse cuts 2012 earnings estimates, citing &quot;weak retail margins, VLO-specific refinery maintenance and weak ethanol margins. With a potentially sluggish patch for the econo... https://seekingalpha.com/news/229451?source=tweet\" data-url=\"https://seekingalpha.com/news/229451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229421\" data-ts=\"1333123676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OC\" target=\"_blank\">OC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman ups the Building Products group to Neutral citing improving sales trends and easing...</a></h4><p>Goldman ups the Building Products group to Neutral citing <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=tpx&amp;days_back=30&amp;table=none\">improving sales trends</a> and easing commodity prices. The firm's top pick in the space is Buy rated Owens Corning (<a href=\"https://seekingalpha.com/symbol/OC\" title=\"Owens Corning\">OC</a> <font color=\"green\">+1%</font>) given its pricing power, and its least favorites remain Sell rated Whirlpool (<a href=\"https://seekingalpha.com/symbol/WHR\" title=\"Whirlpool Corporation\">WHR</a> <font color=\"green\">+0.5%</font>) and USG (<a href=\"https://seekingalpha.com/symbol/USG\" title=\"USG Corporation\">USG</a> <font color=\"red\">-1.8%</font>) given weak fundamentals. </p><div class=\"tiny-share-widget\" data-id=\"229421\" data-linked=\"Goldman ups the Building Products group to Neutral citing improving sales trends and easing...\" data-tweet=\"$OC $OC $WHR - Goldman ups the Building Products group to Neutral citing improving sales trends and easing commodity prices. The firm&#39;s top pick in the space is Buy rated Owens Corning (OC +1%) given its pricing power, and its least favorites remain Sel... https://seekingalpha.com/news/229421?source=tweet\" data-url=\"https://seekingalpha.com/news/229421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229381\" data-ts=\"1333123105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYN\" target=\"_blank\">WYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wyndham (WYN +3%) gets a lift from a Goldman upgrade to Buy, citing improving core fundamentals,...</a></h4><p>Wyndham (<a href=\"https://seekingalpha.com/symbol/WYN\" title=\"Wyndham Worldwide Corporation\">WYN</a> <font color=\"green\">+3%</font>) gets a lift from a Goldman <a target=\"_blank\" href=\"http://www.benzinga.com/pre-market-outlook/12/03/2459596/wyndham-worldwide-up-2-on-goldman-sachs-upgrade\">upgrade to Buy</a>, citing improving core fundamentals, inventory improvements, continued share buybacks, and strong consumer demand. The firm raises estimates above the Street and its price target to $55 from $45.50. </p><div class=\"tiny-share-widget\" data-id=\"229381\" data-linked=\"Wyndham (WYN +3%) gets a lift from a Goldman upgrade to Buy, citing improving core fundamentals,...\" data-tweet=\"$WYN - Wyndham (WYN +3%) gets a lift from a Goldman upgrade to Buy, citing improving core fundamentals, inventory improvements, continued share buybacks, and strong consumer demand. The firm raises estimates above the Street and its price target to $55 ... https://seekingalpha.com/news/229381?source=tweet\" data-url=\"https://seekingalpha.com/news/229381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229341\" data-ts=\"1333122165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After pricing its 9M share IPO at $6, Enphase Energy (NASDAQ:ENPH) opened at $7.40 and is now...</a></h4><p>After <a target=\"_blank\" href=\"http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&amp;newsLang=en&amp;newsId=20120329006744&amp;div=-543468207\">pricing</a> its 9M share IPO at $6, Enphase Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a>) opened at $7.40 and is now trading at $7.32, <font color=\"green\">up 22%</font>. That gives gives the maker of solar <a target=\"_blank\" href=\"http://en.wikipedia.org/wiki/Solar_micro-inverter\">microinverters</a> a valuation of $273M. Enphase generated 2011 revenue of $149.5M (+143% Y/Y), but also a net loss of $32.3M. Its solutions <a target=\"_blank\" href=\"http://gigaom.com/cleantech/enphase-energy-goes-public-ends-solar-ipo-drought/\">convert power more efficiently</a> than traditional solar inverters from the likes of <a href=\"https://seekingalpha.com/symbol/SATC\" title=\"\">SATC</a> and <a href=\"https://seekingalpha.com/symbol/PWER\" title=\"Power - One, Inc.\">PWER</a>, but are also costlier. (<a target=\"_blank\" href=\"http://sec.gov/Archives/edgar/data/1463101/000119312512135817/d195596ds1a.htm\">S-1</a>) </p><div class=\"tiny-share-widget\" data-id=\"229341\" data-linked=\"After pricing its 9M share IPO at $6, Enphase Energy (NASDAQ:ENPH) opened at $7.40 and is now...\" data-tweet=\"$ENPH $ENPH $SATCQ - After pricing its 9M share IPO at $6, Enphase Energy (NASDAQ:ENPH) opened at $7.40 and is now trading at $7.32, up 22%. That gives gives the maker of solar microinverters a valuation of $273M. Enphase generated 2011 revenue of $149.... https://seekingalpha.com/news/229341?source=tweet\" data-url=\"https://seekingalpha.com/news/229341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229251\" data-ts=\"1333120927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRTX\" target=\"_blank\">XRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xyratex&amp;rsquo;s (XRTX -10.2%) Q1 earnings surged on improved margins and lower input costs, but...</a></h4><p>Xyratex\u2019s (<a href=\"https://seekingalpha.com/symbol/XRTX\" title=\"Xyratex Ltd.\">XRTX</a> <font color=\"red\">-10.2%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227921\">Q1 earnings</a> surged on improved margins and  lower input costs, but shares are sliding due to weaker  revenue on supply problems and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228021\">downward Q2 guidance</a>. While still liking XTRX long-term, Needham <a target=\"_blank\" href=\"http://www.streetinsider.com/Downgrades/Needham+%26+Company+Downgrades+Xyratex+%28XRTX%29+to+Hold%3B+Valuation+Call/7308703.html\">downgrades</a> shares to Hold from Buy on valuation, slightly reduced FY 2013 results, and absence of any apparent catalyst to move  estimates. </p><div class=\"tiny-share-widget\" data-id=\"229251\" data-linked=\"Xyratex\u2019s (XRTX -10.2%) Q1 earnings surged on improved margins and lower input costs, but shares...\" data-tweet=\"$XRTX - Xyratex\u2019s (XRTX -10.2%) Q1 earnings surged on improved margins and lower input costs, but shares are sliding due to weaker revenue on supply problems and downward Q2 guidance. While still liking XTRX long-term, Needham downgrades shares to Hold ... https://seekingalpha.com/news/229251?source=tweet\" data-url=\"https://seekingalpha.com/news/229251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229241\" data-ts=\"1333120805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of ImmunoGen (IMGN +4.1%) lose traction after shooting up over 12% on positive results...</a></h4>Shares of ImmunoGen (<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color=\"green\">+4.1%</font>) lose traction after shooting up over 12% on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228841\">positive results</a> from partner Roche for its experimental breast cancer drug. The rally got cut short in part by the <a target=\"_blank\" href=\"www.thestreet.com/story/11476972/1/immunogen-is-over-valued.html\">opinion</a> that the market value on IMGN is \"significantly\" too high based on the small 5% royalty tied to Roche's drug.<div class=\"tiny-share-widget\" data-id=\"229241\" data-linked=\"Shares of ImmunoGen (IMGN +4.1%) lose traction after shooting up over 12% on positive results...\" data-tweet=\"$IMGN - Shares of ImmunoGen (IMGN +4.1%) lose traction after shooting up over 12% on positive results from partner Roche for its experimental breast cancer drug. The rally got cut short in part by the opinion that the market value on IMGN is &quot;significan... https://seekingalpha.com/news/229241?source=tweet\" data-url=\"https://seekingalpha.com/news/229241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229141\" data-ts=\"1333118916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MM\" target=\"_blank\">MM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millennial Media (MM -8.8%) and Annie&#39;s (BNNY -3.6%) cool off after delivering scorching IPOs...</a></h4><p>Millennial Media (<a href=\"https://seekingalpha.com/symbol/MM\" title=\"Millennial Media, Inc.\">MM</a> <font color=\"red\">-8.8%</font>) and Annie's (<a href=\"https://seekingalpha.com/symbol/BNNY\" title=\"Annie's, Inc.\">BNNY</a> <font color=\"red\">-3.6%</font>) cool off after delivering scorching IPOs this week (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/226671\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/224511\">II</a>) that were bolstered by relatively small floats. Nonetheless, shares are still up 75% and 92%, respectively, from their IPO prices. </p><div class=\"tiny-share-widget\" data-id=\"229141\" data-linked=\"Millennial Media (MM -8.8%) and Annie&#39;s (BNNY -3.6%) cool off after delivering scorching IPOs...\" data-tweet=\"$MM $MM $BNNY - Millennial Media (MM -8.8%) and Annie&#39;s (BNNY -3.6%) cool off after delivering scorching IPOs this week (I, II) that were bolstered by relatively small floats. Nonetheless, shares are still up 75% and 92%, respectively, from their IPO pr... https://seekingalpha.com/news/229141?source=tweet\" data-url=\"https://seekingalpha.com/news/229141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229121\" data-ts=\"1333118097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Sirius XM (SIRI +4.3%) show a pesky gain after reports swirl around that Liberty Media...</a></h4>Shares of Sirius XM (<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a> <font color=\"green\">+4.3%</font>) show a pesky gain after reports swirl around that Liberty Media (LMCA <font color=\"green\">+1.1%</font>) is closing in on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/222441\" target=\"_blank\">adding to</a> its ownership stake in the company and vying to gain <a target=\"_blank\" href=\"https://seekingalpha.com/article/467491-liberty-media-seeking-de-facto-control-of-sirius-xm\">\"de facto\" control</a> of some Sirius' licenses and assets via an investor agreement between the firms.<div class=\"tiny-share-widget\" data-id=\"229121\" data-linked=\"Shares of Sirius XM (SIRI +4.3%) show a pesky gain after reports swirl around that Liberty Media...\" data-tweet=\"$SIRI $SIRI $FWONA - Shares of Sirius XM (SIRI +4.3%) show a pesky gain after reports swirl around that Liberty Media (LMCA +1.1%) is closing in on adding to its ownership stake in the company and vying to gain &quot;de facto&quot; control of some Sirius&#39; license... https://seekingalpha.com/news/229121?source=tweet\" data-url=\"https://seekingalpha.com/news/229121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229091\" data-ts=\"1333117366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBSAA\" target=\"_blank\">SBSAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Spanish Broadcasting Systems (SBSA +41.1%) skyrocket after the firm reports that it...</a></h4><p>Shares of Spanish Broadcasting Systems (SBSA <font color=\"green\">+41.1%</font>) skyrocket after the firm <a target=\"_blank\" href=\"http://finance.yahoo.com/news/spanish-broadcasting-system-inc-reports-130000286.html\">reports</a> that it quadrupled profits in Q4 compared to last year. The company says it increased national radio sales in the New York and Puerto Rico markets.</p><div class=\"tiny-share-widget\" data-id=\"229091\" data-linked=\"Shares of Spanish Broadcasting Systems (SBSA +41.1%) skyrocket after the firm reports that it...\" data-tweet=\"$SBSAA - Shares of Spanish Broadcasting Systems (SBSA +41.1%) skyrocket after the firm reports that it quadrupled profits in Q4 compared to last year. The company says it increased national radio sales in the New York and Puerto Rico markets. https://seekingalpha.com/news/229091?source=tweet\" data-url=\"https://seekingalpha.com/news/229091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229081\" data-ts=\"1333117304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense (INVN -6.3%) tumbles after Oppenheimer downgrades shares to Perform. The firm is...</a></h4><p>InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"red\">-6.3%</font>) tumbles after Oppenheimer <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/03/2459807/update-oppenheimer-downgrades-invensense-to-perform\">downgrades</a> shares to Perform. The firm is worried about InvenSense's May 15 lockup expiration, which will result in 45% of its float being available, and thinks the motion sensor chip market is more open to competition than previously believed. Both Microsoft's Kinect and rival chipmakers such as <a href=\"https://seekingalpha.com/symbol/STM\" title=\"STMicroelectronics NV\">STM</a> and <a href=\"https://seekingalpha.com/symbol/MXIM\" title=\"Maxim Integrated Products, Inc.\">MXIM</a> are seen as threats. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/198641\">previously</a>) </p><div class=\"tiny-share-widget\" data-id=\"229081\" data-linked=\"InvenSense (INVN -6.3%) tumbles after Oppenheimer downgrades shares to Perform. The firm is...\" data-tweet=\"$INVN $INVN $STM - InvenSense (INVN -6.3%) tumbles after Oppenheimer downgrades shares to Perform. The firm is worried about InvenSense&#39;s May 15 lockup expiration, which will result in 45% of its float being available, and thinks the motion sensor chip ... https://seekingalpha.com/news/229081?source=tweet\" data-url=\"https://seekingalpha.com/news/229081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"229031\" data-ts=\"1333116309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DANG\" target=\"_blank\">DANG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/229031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Dangdang (DANG +5.5%) run higher on high trading volume after the company locks in a...</a></h4><p>Shares of Dangdang (<a href=\"https://seekingalpha.com/symbol/DANG\" title=\"E-Commerce China Dangdang Inc.\">DANG</a> <font color=\"green\">+5.5%</font>) run higher on high trading volume after the company locks in a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228141\">deal</a> to offer Gome Online's products in its online marketplace.</p><div class=\"tiny-share-widget\" data-id=\"229031\" data-linked=\"Shares of Dangdang (DANG +5.5%) run higher on high trading volume after the company locks in a...\" data-tweet=\"$DANG - Shares of Dangdang (DANG +5.5%) run higher on high trading volume after the company locks in a deal to offer Gome Online&#39;s products in its online marketplace. https://seekingalpha.com/news/229031?source=tweet\" data-url=\"https://seekingalpha.com/news/229031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228881\" data-ts=\"1333114468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEL\" target=\"_blank\">TEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs upgrades TE Connectivity (TEL +3.1%) to Conviction Buy and takes its price target...</a></h4><p>Goldman Sachs <a target=\"_blank\" href=\"http://www.streetinsider.com/Hot+Upgrades/Goldman+Sachs+Upgrades+TE+Connectivity+%28TEL%29+to+Conviction+Buy/7308587.html\">upgrades</a> TE Connectivity (<a href=\"https://seekingalpha.com/symbol/TEL\" title=\"TE Connectivity Ltd.\">TEL</a> <font color=\"green\">+3.1%</font>) to Conviction Buy and takes its price target on shares up to $45. The firm says TEL makes a good play for betting on electronics growth in the auto industry.</p><div class=\"tiny-share-widget\" data-id=\"228881\" data-linked=\"Goldman Sachs upgrades TE Connectivity (TEL +3.1%) to Conviction Buy and takes its price target...\" data-tweet=\"$TEL - Goldman Sachs upgrades TE Connectivity (TEL +3.1%) to Conviction Buy and takes its price target on shares up to $45. The firm says TEL makes a good play for betting on electronics growth in the auto industry. https://seekingalpha.com/news/228881?source=tweet\" data-url=\"https://seekingalpha.com/news/228881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228871\" data-ts=\"1333114146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finish Line (NASDAQ:FINL) -8.2% premarket despite reporting a 22% jump in Q4 earnings, as the...</a></h4><p>Finish Line (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a>) <font color=\"red\">-8.2%</font> premarket despite reporting a 22% jump in <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228471\">Q4 earnings</a>, as the retailer guides Q1 and FY13 EPS below consensus. Analysts had been bullish about FINL\u2019s prospects as they touted an expected focus on licensed apparel, product launches tied to the Olympics and the growth of a specialty running chain the company had bought last year. </p><div class=\"tiny-share-widget\" data-id=\"228871\" data-linked=\"Finish Line (NASDAQ:FINL) -8.2% premarket despite reporting a 22% jump in Q4 earnings, as the...\" data-tweet=\"$FINL - Finish Line (NASDAQ:FINL) -8.2% premarket despite reporting a 22% jump in Q4 earnings, as the retailer guides Q1 and FY13 EPS below consensus. Analysts had been bullish about FINL\u2019s prospects as they touted an expected focus on licensed apparel,... https://seekingalpha.com/news/228871?source=tweet\" data-url=\"https://seekingalpha.com/news/228871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228841\" data-ts=\"1333113790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen (NASDAQ:IMGN) +12.9% premarket after drug partner Roche (OTCQX:RHHBY) reports positive...</a></h4><p>ImmunoGen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a>) <font color=\"green\">+12.9%</font> premarket after drug partner Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/228751\">reports positive results</a> from a late-stage study of its experimental breast cancer drug T-DM1, paving the way to file the potential blockbuster drug for regulatory approval in Europe and the U.S. later this year. </p><div class=\"tiny-share-widget\" data-id=\"228841\" data-linked=\"ImmunoGen (NASDAQ:IMGN) +12.9% premarket after drug partner Roche (OTCQX:RHHBY) reports positive...\" data-tweet=\"$IMGN $IMGN $RHHBY - ImmunoGen (NASDAQ:IMGN) +12.9% premarket after drug partner Roche (OTCQX:RHHBY) reports positive results from a late-stage study of its experimental breast cancer drug T-DM1, paving the way to file the potential blockbuster drug for... https://seekingalpha.com/news/228841?source=tweet\" data-url=\"https://seekingalpha.com/news/228841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228831\" data-ts=\"1333113751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITD\" target=\"_blank\">KITD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KIT Digital (OTC:KITD) +8.3% premarket, adding to the gains seen yesterday on account of M&amp;amp;A...</a></h4><p>KIT Digital (<a href=\"https://seekingalpha.com/symbol/KITD\" title=\"KIT digital, Inc.\">OTC:KITD</a>) <font color=\"green\">+8.3%</font> premarket, adding to the gains seen yesterday on account of <a target=\"_blank\" href=\"https://seekingalpha.com/article/467181-research-in-motion-limited-s-ceo-discusses-q4-2012-results-earnings-call-transcript\">M&amp;A speculation</a>. KIT's recent <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/217381\">management/board shakeup</a>, along with the <a target=\"_blank\" href=\"http://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1332792000000&amp;chddm=126750&amp;chls=IntervalBasedLine&amp;q=NASDAQ:KITD&amp;ntsp=0\">weak performance</a> of its shares over the last 15 months, has many thinking the IPTV software firm may finally be open to a deal. </p><div class=\"tiny-share-widget\" data-id=\"228831\" data-linked=\"KIT Digital (OTC:KITD) +8.3% premarket, adding to the gains seen yesterday on account of M&amp;amp;A...\" data-tweet=\"$KITD - KIT Digital (OTC:KITD) +8.3% premarket, adding to the gains seen yesterday on account of M&amp;A speculation. KIT&#39;s recent management/board shakeup, along with the weak performance of its shares over the last 15 months, has many thinking the IPTV so... https://seekingalpha.com/news/228831?source=tweet\" data-url=\"https://seekingalpha.com/news/228831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228821\" data-ts=\"1333113712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of LinkedIn (LNKD) move up 2.9% premarket after Susquehanna raises its rating on the...</a></h4><p>Shares of LinkedIn (LNKD) move <font color=\"green\">up 2.9%</font> premarket after Susquehanna <a target=\"_blank\" href=\"https://twitter.com/#!/AmericanEtrader/status/185710612666515456\">raises</a> its rating on the company to Positive from Neutral. The company has also seen some \n<a target=\"_blank\" href=\"http://finviz.com/insidertrading.ashx?tc=7\">insider buying</a></p><div class=\"tiny-share-widget\" data-id=\"228821\" data-linked=\"Shares of LinkedIn (LNKD) move up 2.9% premarket after Susquehanna raises its rating on the...\" data-tweet=\"$MSFT - Shares of LinkedIn (LNKD) move up 2.9% premarket after Susquehanna raises its rating on the company to Positive from Neutral. The company has also seen some insider buying https://seekingalpha.com/news/228821?source=tweet\" data-url=\"https://seekingalpha.com/news/228821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228741\" data-ts=\"1333112447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: IMGN +13%. OTC:KITD +9%. THLD + 4 ARNA +4%. VVUS +3%. GLUU +3%. LNKD +3%. RIO...</a></h4><p>Premarket gainers: <a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/KITD\" title=\"KIT digital, Inc.\">OTC:KITD</a> <font color=\"green\">+9%</font>. THLD + 4 <a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"green\">+4%</font>. <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+3%</font>. <a href=\"https://seekingalpha.com/symbol/GLUU\" title=\"Glu Mobile Inc.\">GLUU</a> <font color=\"green\">+3%</font>. LNKD <font color=\"green\">+3%</font>. <a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a> <font color=\"green\">+3%</font>.<br>Losers: <a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"red\">-5%</font>. SHPGY <font color=\"red\">-4%</font>. </p><div class=\"tiny-share-widget\" data-id=\"228741\" data-linked=\"Premarket gainers: IMGN +13%. OTC:KITD +9%. THLD + 4 ARNA +4%. VVUS +3%. GLUU +3%. LNKD +3%. RIO...\" data-tweet=\"$IMGN $IMGN $KITD - Premarket gainers: IMGN +13%. OTC:KITD +9%. THLD + 4 ARNA +4%. VVUS +3%. GLUU +3%. LNKD +3%. RIO +3%.Losers: FINL -8%. INVN -5%. SHPGY -4%. https://seekingalpha.com/news/228741?source=tweet\" data-url=\"https://seekingalpha.com/news/228741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228751\" data-ts=\"1333112286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche (OTCQX:RHHBY) unit Genentech reports positive results from a Phase III study of its...</a></h4>\nRoche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) unit Genentech <a target=\"_blank\" href=\"\nRead more: http://www.benzinga.com/news/12/03/2459094/roche-genentechs-trastuzumab-emtansine-showed-positive-phase-iii-results-in-her2-\">reports</a> positive results from a Phase III study of its trastuzumab emtansine breast cancer drug. The study showed patients taking the treatment lived significantly longer without their disease getting worse.<div class=\"tiny-share-widget\" data-id=\"228751\" data-linked=\"Roche (OTCQX:RHHBY) unit Genentech reports positive results from a Phase III study of its...\" data-tweet=\"$RHHBY - Roche (OTCQX:RHHBY) unit Genentech reports positive results from a Phase III study of its trastuzumab emtansine breast cancer drug. The study showed patients taking the treatment lived significantly longer without their disease getting worse. https://seekingalpha.com/news/228751?source=tweet\" data-url=\"https://seekingalpha.com/news/228751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228711\" data-ts=\"1333111739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS initiates coverage of Lululemon (NASDAQ:LULU) with a Buy rating and lofty $91 price target....</a></h4><p>UBS <a target=\"_blank\" href=\"http://www.streetinsider.com/Hot+New+Coverage/UBS+Starts+Lululemon+Athletica+Inc.+%28LULU%29+at+Buy/7308560.html\">initiates coverage</a> of Lululemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) with a Buy rating and lofty $91 price target. Shares <font color=\"green\">+1.68%</font> premarket, +56.7% YTD.</p><div class=\"tiny-share-widget\" data-id=\"228711\" data-linked=\"UBS initiates coverage of Lululemon (NASDAQ:LULU) with a Buy rating and lofty $91 price target....\" data-tweet=\"$LULU - UBS initiates coverage of Lululemon (NASDAQ:LULU) with a Buy rating and lofty $91 price target. Shares +1.68% premarket, +56.7% YTD. https://seekingalpha.com/news/228711?source=tweet\" data-url=\"https://seekingalpha.com/news/228711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228581\" data-ts=\"1333109073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs makes the call to buy shares of Mosaic (NYSE:MOS) on weakness with its view that...</a></h4><p>Goldman Sachs <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Says+Buy+Mosaic+%28MOS%29+On+Weakness+After+Q3+Miss/7308697.html\">makes the call</a> to buy shares of Mosaic (NYSE:<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a>) on weakness with its view that the long-term story on the company remains positive and value will eventually be unlocked. Analysts with the firm raised their price target on shares to $71 from $67. Shares <font color=\"green\">+0.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"228581\" data-linked=\"Goldman Sachs makes the call to buy shares of Mosaic (NYSE:MOS) on weakness with its view that...\" data-tweet=\"$MOS - Goldman Sachs makes the call to buy shares of Mosaic (NYSE:MOS) on weakness with its view that the long-term story on the company remains positive and value will eventually be unlocked. Analysts with the firm raised their price target on shares t... https://seekingalpha.com/news/228581?source=tweet\" data-url=\"https://seekingalpha.com/news/228581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228551\" data-ts=\"1333108702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma...</a></h4><p>Threshold Pharmaceuticals (THLD) <a target=\"_blank\" href=\"http://www.streetinsider.com/Corporate+News/UPDATE%3A+Threshold+Pharma+%28THLD%29+Receives+Orphan+Drug+Status+for+TH-302+for+the+Treatment+of+Soft+Tissue+Sarcoma/7308668.html\" _blank>receives</a> FDA orphan drug designation for its TH-302 sarcoma treatment. Shares <font color=\"green\">+6.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"228551\" data-linked=\"Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma...\" data-tweet=\"$MTEM - Threshold Pharmaceuticals (THLD) receives FDA orphan drug designation for its TH-302 sarcoma treatment. Shares +6.9% premarket. https://seekingalpha.com/news/228551?source=tweet\" data-url=\"https://seekingalpha.com/news/228551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"228481\" data-ts=\"1333106483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/228481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Vivus (NASDAQ:VVUS) move up 4.2% in premarket trading as the dust still clears from a...</a></h4><p>Shares of Vivus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a>) <font color=\"green\">move up 4.2%</font> in premarket trading as the dust still clears from a FDA panel that had <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/227751\">implications</a> for weight-loss drug Qnexa. Yesterday's <a target=\"_blank\" href=\"http://blogs.wsj.com/marketbeat/2012/03/29/chart-of-the-day-itchy-trader-fingers-on-vivus/\">roller coaster ride</a> for VVUS may have been a bit of a case of \"itchy trader fingers\" with the final word on FDA approval for Qnexa still up in the air.\n</p><div class=\"tiny-share-widget\" data-id=\"228481\" data-linked=\"Shares of Vivus (NASDAQ:VVUS) move up 4.2% in premarket trading as the dust still clears from a...\" data-tweet=\"$VVUS - Shares of Vivus (NASDAQ:VVUS) move up 4.2% in premarket trading as the dust still clears from a FDA panel that had implications for weight-loss drug Qnexa. Yesterday&#39;s roller coaster ride for VVUS may have been a bit of a case of &quot;itchy trader f... https://seekingalpha.com/news/228481?source=tweet\" data-url=\"https://seekingalpha.com/news/228481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":44,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}